1/46
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
ACNE
due to increased andorgen and sebaceous gland activity
types of acne
non-onflammatory comedonal acne
open comedones (blackheads)
closed comedones (whiteheads)
inflammatory (papulopustular) acne
treatment principles
treated as chronic disease
target all 4 mechansims of acne development
maintanence therapy and lifestyle modifications
non-pharm recommendations
balanced healthy diet
stress control
wash affected area no more than 2x daily w/ non-fragranced glycerin soaps or soapless cleanser
avoid heavy scrubbing
use gentle cleansers, sunscreen, sun protectants
use non-comedogenic make up products
cleanser after workouts
use oil free, water-based moisturizers
avoid scratching, picking, popping lesions
mild - mod non-inflammatory (comedonal) acne treatment
goal
1st line
2nd line/alternative
goal
decrease keratinocyte and sebum blockage
1st line
topical retinoids
adapalene (highest efficacy), tazarotene, tretinoin
benzoyl peroxide
combo: topical + benzoyl = more effective
2nd line/alternative
azelaic acid
topical retinoids
MOA
ADR
precautions
MOA
comedlytic
anti-inflammation
synergisitic w/ topical antibiotics
ADR
skin dryness, photosensitvity
skin discoloration, swelling, blistering
precautions
increased skin toxicity, sun sensitivity, skin erosion
fetal harm risk
Benzoyl peroxide
MOA
ADR
precautions
MOA
keratolytic
antibacterial
improve inflammatory and non-inflammatory lesions
ADR
dry skin
precautions
bleaching
skin peeling
safe in pregnancy
azelaic acid
MOA
ADR
precautions
pregnancy
MOA
activity against all 4 pathogenic mechanisms of acne
keratinization, anti-inflammatory, anti-bacterial
ADR
burning, pruritus, stinging
precautions
hypopigmentation
pregnancy
safe
less effective than other 1st lines
T or F: combo topical retinoids, benzoyl peroxide, azelaic acid is okay
True
Mild-mod inflammatory (papulopustular) acne treatment
goal
1st line
alternative
widespread disease
goal
reduction of C. acnes colonization
1st line
adapalene + benzoyl peroxide
topical clindamycin + benzoyl peroxide
alternative
different topical retinoid w/ other antimicrobial agent (Dapsone, Erythromycin) w/ or w/o benzoyl peroxide
widespread disease
combo of sysyemic antibiotic w/ benzoyl peroxide OR
combo of systemic antibiotic w/ fixed dose combo of benzoyl peroxide + adapalene
topical antibacterials: Clindamycin, Erythromycin
MOA
notes
MOA
reduce C. acnes
notes
increasingly less effective due to resistance
addition of benzoyl peroxide or topical retinoids more effective than monotherapy
topical antibacterial agent: Dapsone 5% topical gel
MOA
use
ADR
MOA
synthetic sulfone w/ anti-inflammatory and anti-bacterial
use
okay in pts w/ sulfonamide allerfy
improve inflammatory and non-inflammatory acne
increased efficacy in females
ADR
dry skin, erythema, peeling
T or F: antibacterial agents should be used alone
False, do not use these alone
clindamycin + tretinoin (alternative agent) ADR
increased risk of sunburn
systemic antibiotics
type of antibiotic
agents
MOA
type of antibiotic
tetracycline
agents
minocycline
doxycycline
MOA
reduce C acnes
side effects
minocycline
doxycycline
minocycline
photosensitivity
doxycycline
photosensitivty
avoid isotretinoin use concomitantly
severe inflammatory (papulopustular, nodular, cystic) acne treatment
1st line
2nd line
alternative therapies
1st line
oral isotretinoin monotherapy
2nd line
alternative ststemic antibiotics +
fixed dose adapalene-benozoyl peroxide combo OR
adapalene-azelaic acid combo
alternative therapies
anti-androgen in combo w/ oral antibiotics
topical treatments
systemic antibiotics in combo w/ benzoyl peroxide
oral isotretinoin
MOA
goal dose
SEs
precautions
CI
BBW
MOA
synthetic analog of Vitamin A
inhibit sebaceous gland function and keratinazation
reduce inflammation
goal dose
cumulative dose of 120 mg/kg over 4 - 6 months
SEs
photosensitivity, anemia, increased LFTs
thrombosis, neutropenia, thrombocytopenia, neuritis, depression, psych disorders
precautions
avoid use of tetracycline, vit A supplements, John worts
risk of scarring up to 6 months
CI
pregnancy
BBW
pregnancy X
high risk of birth defects
iPLEDGE REMS program
goal
who must be registered/activated
to prevent fetal exposure
prescribers, pharmacies, patients
other treatmenrs for hormonal acne (for females)
antiandrogen compounds
oral contraceptives (estrogen/progesterone)
spironolactone
light therapies
oral contraceptives (estrogen/progesterone)
beneficial if acne is menstrual or ovarian disease-related
may be superior to oral antibiotics for long term maintenance
spironolactone
MOA
SEs
precautions
MOA
antihypertensive
interferes w/ testosterone biosynthesis
SEs
gynecomastia
erectile dysfunction
hyperkalemia
T or F: hormone therapy (spironolactone + OC) should not be combined with each other
true, however sprinolactone can be combined with systemic antibiotics and topicals
T or F: light therapies are a weak recommendation
true
Maintenance therapy
1st line
alternative
other
1st line
topical retinoids
alternative
azelaic acid
other
continue hormonal therapy if it works
long term therapy w/ oral antibiotics NOT recommended
2nd course of isotretinoin
URTICARIA (HIVES)
due to allergic reactions
type 1 immediate hypersensitivity (IgE-mediated)
urticarial rash
treatment of new onset urticaria
often self-limiting
1st gen AH
2nd gen AH
systemic glucocorticoids
1st gen AH
agents
MOA
ADR
precautions
agents
diphenhydramine
chlorpheniramine
hydroxyzine
MOA
lipophilic
ADR
sedation
dizziness
xerostomia
anti-SLUD
precautions
2nd gen AH
agents
advantages
agents
cetirizine
loratidine
fexofenadine
advantages
safer in older adults, no sedation
is it okay to take 1st and 2nd gen AH
yes, if separated
systemic glucocorticoid (Prednisone or equivalent)
not necessary for isolated urticaria
may be needed if angioedema present
does not inhibit mast cell degranulation, but suppress inflammatory mechanisms
when to refer / emergency attention
suspiciion of anaphylactic reaction
difficulity breathing
throat closure
wide-spread and worsening sxs
severe angioedema
angioedema in face
prescribe epi for self-injection
ROSACEA clinical features
due to abnormalities in innate immunity
centrofacial erythema
papules, pustules
flushing
spider veins (telangiectasias)
burning, stinging
edema
dry skin
ocular involvement
exacerbating factors of rosacea
temp changes
sun exposure
alcohol
spicy foods
skin irritants
vasodilators
treatment of rosacea
vascular features
facial erythema
papules and pustules
vascular features
laser and intense pulse light
facial erythema
vasoactive alpha 2 adrenergic receptor agonists
topical brimonidine
topical oxymetazoline
papules and pustules
topical metronidazole
topical ivermectin
topical azelaic acid
DRUG INDUCED SKIN RXNS
epidemiology
pathophysiology
epidemiology
prevalent in women and elderly pts
pathophysiology (non-immuno mediated)
accumulation and direct release of mast cell mediators: dose dependent (ASA, NSAIDs, hydralazine, vanco, opiates)
intolerance: due to altered metabolism
Jarisch-Herxheimer phenomenon: result of bacterial endotoxins/microbial antigens released by microorganism destruction
overdosage or phototoxic dermatitis
classifications of ADE
type A
type B
type A
associated w/ therapeutic dosafes
predictable and avoidable
type B
independent of dose
rarely predictable or avoidable
uncommon but serious and life-threatening
types of immuno-mediated (type B) reactions
type 1
type 2
type 3
type 4
type 1
immediate hypersensitivity
IgE, mast cells
type 2
cytotoxic
IgE mediated
hemolysis, thrombocytopenia, purpura
type 3
immune-complex
IgG-drug complex
vasculitis, serum sickness, urticaria
type 4
delayed
contact dermatitis, exanthematous rxns, photoallergic rxns
acute types of drug-induced skin rns and causative agents
erythematous multiforme/morbilliform eruptions
type 4
starts at trunk, extends to extremeties
spares face, palms, soles, mucous membranes
PCNs, cephalosporins, sulfonamides, anticonvulsants, allopurinol
urticaria, angioedema, anaphylaxis
NSAIDs, vanco, ACEis, chemo, opiates
hypersensitivity syndrome (DRESS)
fever, exanthem, internal organ invovled
lead to dermatitis, facial edema, etc
allopurinol, sulfonamides, anticonvulsants, vanco, dapsone, minocylcine
SJS and TEN
life threatening
SJS: < 10% BSA
SJS-TEN: 10 - 30% BSA
TEN: > 30%
high risk for infection and sepsis
allopurinol, sulfonamides, anticonvulsants
warfarin-induced
serum sickness like rxns
cefaclor, minocycline, PCNs
photosensitivtity
FQs, amiodarone, MTX, furosemide, TCNs, sulfonamides, thiazides, sulfonylureas, ACEis, CCBs
HLA-B1502 allele
high risk for CBZ-induced SJS/TEN
high prevalence in asian population
HLB5801 allele
high risk for allopurinol induced hypersensitivity syndorme (SCARs)
common in asian populations
T or F: do not rechallenge w/ drugs causing urticaria, bullae, angioedema, DRESS< anaphylaxis, erythema multiforme
true
chronic types of drug induced skin reactions
drug-induced lupus
associated w/ Hydralazine, Procainamide, Quinidine, Isoniazid, Methyldopa, Minocycline
drug induced ance
different from acne vulgaris by absence of gross and/or microscopic comedones
associtated w/ corticosteroifs, androgenic hormones, lithium, isonizad, azathioprine, EGFR inhibitors
use topical acne treatments to manage
corticosteroid ADR: glucocortico
glacuoma
lunacy (mood swings)
ulceration
cushings
osteoporosis
cataracts
opportunistic infections
retention of Na
telangiectasia
insulin resistance (hyperglycemia)
causes of muscle weakness
growth retarfation